Gosset Ownership
Private
Therapeutic Areas
Stage
Phase 1
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Cellcolabs General Information
Conducting trials in the Bahamas through subsidiary Cellcolabs Clinicals to assess MSCs in cardiovascular disease prevention and musculoskeletal injuries. Treatment is carried out through local injection or systemic infusion[4].
Contact Information
Drug Pipeline
No pipeline data available
Key Partnerships
Collaborations with university hospitals and biotechnology companies[3][4]
Cellcolabs Funding
No funding data available
To view Cellcolabs's complete valuation and funding history, request access »